Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Fatigue in Multiple Sclerosis: Neural Correlates and the Role of Non-Invasive Brain Stimulation.
FDA approval of Isentress (raltegravir)
Neurodegeneration and Neuroprotection in Multiple Sclerosis.
Peripheral neuropathy associated with mitochondrial disease in children.
Accidental natalizumab administration in pregnancy in multiple sclerosis.
AP-1 Mediated Transcriptional Repression of Matrix Metalloproteinase-9 by Recruitment of Histone Deacetylase 1 in Response to Interferon β.
Cerebellar-parietal dysfunctions in multiple sclerosis patients with cerebellar signs.
Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis.
Cell intrinsic role of NF-κB-inducing kinase in regulating T cell-mediated immune and autoimmune responses.
Compassionate Use Programme Update
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.
The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration.
Mechanisms in the Development of Multiple Sclerosis Lesions: Reconciling Autoimmune and Neurodegenerative Factors.
Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy.
Natural, innate improvements in multiple sclerosis disability.
The role of interleukin-6 signaling in nervous tissue.
Late sodium channel openings underlying epileptiform activity are preferentially diminished by the anticonvulsant phenytoin.
Use of Neurofeedback to Enhance Response to Hypnotic Analgesia in Individuals With Multiple Sclerosis.
Estimating the proportion of variation in susceptibility to multiple sclerosis captured by common SNPs.
Percutaneous transluminal angioplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: dichotomy between subjective and objective outcome scores.
Consensus statements from a panel of u.s. Managed care pharmacists and physicians for management of multiple sclerosis agents.
A CB(1)/CB(2) receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin.
Estimated incidence of multiple sclerosis among United States Armed Forces personnel using the Defense Medical Surveillance System.
Tract-based spatial statistics analysis of diffusion-tensor imaging data in pediatric- and adult-onset multiple sclerosis.
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.

Pages